PHILADELPHIA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Chardan's 7th Annual Genetic Medicines Conference on Monday, October 2, 2023 at 5:00 p.m ET.
A live webcast of the event will be available on the Investors & Media section of Passage Bio's website at investors.passagebio.com. A replay of the ...